Shaveta Vinayak MD, MS

Dr. Shaveta Vinayak is a medical oncologist who specializes in the treatment of breast cancer. His research is focused on an aggressive subtype known as triple-negative breast cancer, which tends to affect younger people and those with a BRCA1 gene mutation. He designs and lead clinical trials that explore targeted therapies like immune checkpoint inhibitors, which help the immune system recognize and attack cancer cells, and PARP inhibitors, a type of drug that may prevent cancer cells from fixing the damage caused by chemotherapy.